Search Results for "joyner"
Screening for atrial fibrillation with a wearable patch: Seek and ye shall find … and then what?
A study published yesterday in the Journal of the American Medical Association (JAMA) raises important questions about the implications of widespread screening for atrial fibrillation — our most common abnormal heart rhythm (or, “arrhythmia”). Atrial fibrillation (“AF” or “AFib” for short) is an irregular beating of the heart’s two upper chambers, and is considered a […]4
NIH uses dodgy PR to enroll one million Americans in its ‘All of Us’ precision medicine program
Something huge, expensive, arguably controversial and allegedly revolutionary happened on Sunday to modest fanfare. Three years after it was announced by President Barack Obama, the ambitious precision health initiative — now rebranded as the “All of Us” research program — was launched by the National Institutes of Health (NIH) in 7 cities across the United […]
Podcast: The promise of precision medicine
In the past half year the FDA approved the first three gene therapies for use in the US.
This comes less than 18 years after the announcement that the human genome had been fully sequenced. It was a milestone wrapped in a promise; a promise that became known as “precision medicine.” But has that promise become reality?
In this podcast we turn to five leaders in their respective fields who’ve been intimately involved with this emerging technology. We ask them them to not only contrast what precision medicine is and may become, but also to help us clarify what holds promise and what’s just hype.
Blood pressure, dietary salt, and genes: What happens when the dots don’t connect?
Blood pressure, dietary salt, and how genes influence human biology are among the most frequently reported health-related topics in the media. In the last couple of weeks the new and lower blood pressure guidelines have been widely publicized and critically analyzed; salt is always in the news; and there is no shortage of stories about […]3
FDA approves 23andMe’s at-home DNA test, but bathroom scale may work just as well for predicting health
One of the big stories last week was that 23andMe, a consumer genomics company, was the first company of its kind to receive FDA permission to provide information directly to consumers about their risk of developing diseases or conditions. Although there are many companies offering at-home genetic testing–whereby a person sends in a saliva sample, along with between […]
Too much sitting ages you 8 years? Lazy headlines and a lost opportunity to educate about telomeres
“Sitting too much ages you by 8 years.” That was TIME’s lazy headline yesterday about a study on the effects of physical activity on telomeres. Telomeres are the caps at the ends of DNA strands that protect our genetic information. Every time our cells replicate, the caps get a little bit shorter and a little […]
PARP inhibitors: STAT’s look at new ovarian cancer drugs should have established why we need more on the market
Do we really need more PARP inhibitors beyond the one that’s already approved? If so, why? This story didn’t clarify these things for readers.
The race to create a new class of ovarian cancer drugs heats up
Poking holes in Pokémon Go health benefit claims–including a study that didn’t exist
We’ve been tracking some wild and unsubstantiated claims of health benefits from the use of the Pokémon Go app. A quick web search turns up thousands of articles with headlines that read more like advertising than journalism – making claims about impact on obesity, type 2 diabetes, anxiety, depression, and more. Stories have: called it “a health […]1
Fixing the health care system: Four facts to focus on when reading election year health policy stories
The following guest post is by Michael Joyner, MD, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on Twitter @DrMJoyner. It’s an election year, which means that candidates, political parties, and interest groups are shopping their plans for how to fix our health care system in the news […]1
The Cancer Moonshot: A perspective in 4 graphs
The following guest post is by Michael Joyner, MD, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on Twitter @DrMJoyner. It has been almost six months since the “Cancer Moonshot” initiative was proposed by President Obama. Here are some reflections on all of the hype surrounding the initiative […]2
Behind the “Biggest Loser” study headlines — a lost opportunity to educate about weight loss options
The following guest post is by Dr. Michael Joyner, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on Twitter @DrMJoyner. One of the biggest health news stories last week was about the long term weight loss results reported in 14 participants from the Biggest Loser reality […]1
Cross-border media comparison: Insurance coverage linked to news coverage of expensive cystic fibrosis drug
The following guest post is by Dr. Michael Joyner, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on Twitter @DrMJoyner. Cystic Fibrosis (CF) is a “common” rare disease affecting about 30,000 Americans and 70,000 people worldwide. There has been much good news about CF over the […]
Wearable monitors: what do we really know?
The following guest post is by Dr. Michael Joyner, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on twitter @DrMJoyner. One of the most interesting pieces of health care reporting I have read in the last couple of weeks was Charles Piller’s article in Stat on leadership […]2
Predictions for Precision Medicine get an evidence-based reality check
The following guest post is by Dr. Michael Joyner, a medical researcher at the Mayo Clinic. These views are his own. You can follow him on twitter @DrMJoyner. One of the key ideas underpinning “Precision Medicine” is that information about the genetic risks for key diseases can be communicated to patients and cause proactive changes […]